𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjects

✍ Scribed by T. M. Ludden; D. A. Boyle; D. Gieseker; G. T. Kennedy; M. H. Crawford; L. K. Ludden; W. A. Clementi

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
538 KB
Volume
77
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

PHARMACOKINETICS AND ABSOLUTE BIOAVAILAB
PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY OF EPRISTERIDE IN HEALTHY MALE SUBJECTS
✍ Lisa Jo Benincosa; Patricia R. Audet; Dave Lundberg; NΓ©vine Zariffa; Diane K. Jo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

The objective of the current investigation was to describe the pharmacokinetics and absolute oral bioavailability of epristeride. Twelve healthy male subjects (mean (SD) age, 27 (6.2) years) received a single oral dose of 5mg and an intravenous infusion of 4.5 mg over 30 min in a crossover fashion.

The relationship between buspirone bioav
The relationship between buspirone bioavailability and dose in healthy subjects
✍ Dr. R. E. Gammans; R. F. Mayol; A. V. MacKenthun; L. F. Sokya πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

Dose dependency of the pharmacokinetics of buspirone, a new anxiolytic agent, was tested in 24 healthy volunteers. Each subject received 10, 20, and 40 mg doses according to a randomized, three-way crossover design with a 7-day interval between treatments. Buspirone AUC values at 10, 20, and 40 mg d

Dose proportionality of reboxetine enant
Dose proportionality of reboxetine enantiomers in healthy male volunteers
✍ E. Rey; P. Dostert; Ph. d'Athis; M.G. Jannuzzo; I. Poggesi; G. Olive πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

Reboxetine is a racemic mixture of FCE 22071 and FCE 21684 enantiomers. The pharmacokinetics of the enantiomers of reboxetine were observed to be linear in male healthy subjects (n = 6) after the administration of 1.5, 3, 4.5 mg dose of reboxetine as solutions. Kinetic analysis was based on chiral H